Skip to content
ePORE Therapy Logo
  • About Mirai
  • Technology
    • What is Electroporation?
    • ePORE® therapy Technology
    • ePORE® therapy Treats
    • Benefits of ePORE® therapy
    • EndoVE®
    • CUTIS
  • Skin Therapy
    • Clinicians
    • Patient Information
  • Gastrointestinal Therapy
    • Clinicians
    • Patient Information
  • News
  • References
  • Contact
Menu
  • About Mirai
  • Technology
    • What is Electroporation?
    • ePORE® therapy Technology
    • ePORE® therapy Treats
    • Benefits of ePORE® therapy
    • EndoVE®
    • CUTIS
  • Skin Therapy
    • Clinicians
    • Patient Information
  • Gastrointestinal Therapy
    • Clinicians
    • Patient Information
  • News
  • References
  • Contact

Author: admin

Filter by Topic
Mirai Medical Launches its New Website and has Received a Favourable Ethical Opinion for the PIONEER Patient Registry
Read More
24.05.2021
First Patient Enrolled in VECTOR Trial using ePORE® therapy for the Treatment of Inoperable Oesophageal and Gastric Cancer
Read More
10.05.2021

Contact Us

By clicking send, you confirm you have read and agreed to Mirai Medical's Privacy Policy.
Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white
Dynamic Meta widget allowed only for Posts listing source or in Post context
Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.
Website by Proactive Design & Marketing